Creating Value by Overcoming Treatment Barriers View previous quarters - Today Latest News View all press releases 08.10.26 Aquestive Therapeutics Announces Positive Topline Human Factors and Pharmacokinetic Study Results for Anaphylm™ (dibutepinephrine) Sublingual Film Read More 07.29.26 Aquestive Therapeutics to Report Second Quarter 2026 Financial Results and Recent Business Highlights on August 11 and Host Conference Call on August 12 at 8:00 a.m. ET Read More 07.07.26 Aquestive Therapeutics to Participate in Leerink Partners Therapeutics Forum: I&I and Metabolism Read More Events View all events Upcoming Events 08.12.26 8:00 AM EDT Q2 2026 Aquestive Therapeutics, Inc. Earnings Conference Call Past Events 05.14.26 8:00 AM EDT Q1 2026 Aquestive Therapeutics, Inc. Earnings Conference Call 03.10.26 8:25 AM EDT Citizens Life Sciences Conference Presentations View all presentations Anaphylm Human Factors and Clinical Study Supplemental Materials Corporate Presentation – February 2026 1.8 MB Anaphylm™ (dibutepinephrine) Sublingual Film Complete Response Letter Supplemental Material 1.1 MB
08.10.26 Aquestive Therapeutics Announces Positive Topline Human Factors and Pharmacokinetic Study Results for Anaphylm™ (dibutepinephrine) Sublingual Film Read More
07.29.26 Aquestive Therapeutics to Report Second Quarter 2026 Financial Results and Recent Business Highlights on August 11 and Host Conference Call on August 12 at 8:00 a.m. ET Read More
07.07.26 Aquestive Therapeutics to Participate in Leerink Partners Therapeutics Forum: I&I and Metabolism Read More
